Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Long-Term Investments (2016 - 2019)

Healthequity has reported Long-Term Investments over the past 5 years, most recently at $81.8 million for Q3 2019.

  • Quarterly results put Long-Term Investments at $81.8 million for Q3 2019, up 99.08% from a year ago — trailing twelve months through Jul 2019 was $81.8 million (up 99.08% YoY), and the annual figure for FY2019 was $709000.0, changed.
  • Long-Term Investments for Q3 2019 was $81.8 million at Healthequity, up from $78.1 million in the prior quarter.
  • Over the last five years, Long-Term Investments for HQY hit a ceiling of $81.8 million in Q3 2019 and a floor of $709000.0 in Q1 2019.
  • Median Long-Term Investments over the past 5 years was $40.3 million (2016), compared with a mean of $43.9 million.
  • Biggest five-year swings in Long-Term Investments: increased 0.52% in 2016 and later skyrocketed 99.08% in 2019.
  • Healthequity's Long-Term Investments stood at $40.1 million in 2015, then rose by 0.62% to $40.4 million in 2016, then rose by 0.3% to $40.5 million in 2017, then grew by 1.57% to $41.1 million in 2018, then skyrocketed by 99.08% to $81.8 million in 2019.
  • The last three reported values for Long-Term Investments were $81.8 million (Q3 2019), $78.1 million (Q2 2019), and $709000.0 (Q1 2019) per Business Quant data.